Novozymes

Novozymes is a corporate investor headquartered in Bagsvaerd.

Novozymes is headquartered in Bagsvaerd.

Altss maintains an OSINT-verified profile of Novozymes covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), assets (real estate, public market positions, private companies, art and cultural holdings, philanthropy and foundations), and network (club memberships, associations, and event participation). Detailed values are available to Altss subscribers.

Novozymes's public website is www.novozymes.com. Verified contact details for principals and decision-makers are available to Altss subscribers.

Novozymes is classified by Altss as a Corporate Investor.

Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.

Novozymes's profile is part of Altss's continuous-refresh dataset, with a full update cycle at least every 30 days and priority changes applied as new information is verified.